High Purity Subcutaneous Injection GS-441524 FIP Treatment For Cats With 20mg 30mg Strength

High Purity Subcutaneous Injection GS-441524 FIP Treatment for Cats with 20mg 30mg Strength

Product Overview

GS-441524 is a widely studied antiviral nucleoside analog designed to inhibit viral replication at the molecular level. It interferes with the viral RNA synthesis process, effectively blocking the reproduction cycle of the virus. As a key metabolite related to remdesivir, it has demonstrated strong stability and bioactivity in antiviral research, especially in veterinary applications.

Key Features & Attributes

• High purity with strict production standards
• Consistent quality across different batches
• Stable formulation suitable for injection use
• Carefully controlled manufacturing process
• Available in multiple vial sizes for flexible use

Mechanism & Functional Advantages

GS-441524 works by mimicking natural nucleosides, inserting itself into the viral RNA chain during replication. Once incorporated, it disrupts further elongation of the RNA strand, thereby halting viral proliferation. This mechanism helps limit viral spread within the body and allows the immune system to respond more effectively.

Compared with other antiviral approaches, GS-441524 offers:

• Targeted antiviral activity
• Reliable performance in viral inhibition studies
• Good tolerance observed in feline-related applications
• Extended activity duration supporting consistent dosing

Application in Feline Infectious Peritonitis (FIP)

GS-441524 has gained significant attention in veterinary use, particularly in the management of Feline Infectious Peritonitis (FIP)—a serious disease caused by mutated feline coronavirus.

FIP mainly affects cats with weakened immune systems and can present in two major forms:

• Wet (Effusive) FIP: Characterized by fluid buildup in the abdomen or chest
• Dry (Non-effusive) FIP: Involves organ inflammation and granuloma formation

Typical symptoms may include:

Loss of appetite, persistent fever, weight loss, lethargy, breathing difficulty, and in some cases neurological or ocular issues.

By suppressing viral replication, GS-441524 helps control disease progression and supports recovery in affected cats.

Recommended Dosage (Reference Only)

Dosage may vary depending on the cat’s condition and veterinary guidance:

• Wet FIP: 0.3 ml/kg body weight + 0.1 ml
• Dry FIP: 0.4 ml/kg body weight + 0.1 ml
• Ocular/Neurological Cases: 0.5 ml/kg body weight + 0.1 ml
• Relapse Cases: 0.6 ml/kg body weight + 0.1 ml

Note: Actual dosage should always follow professional veterinary advice.

Application Scenarios

• Veterinary clinics and animal hospitals
• Cat breeders and catteries
• Pet health research and antiviral studies
• Specialized feline treatment programs

Shipping & Supply

• Stable supply with reliable production capacity
• Secure packaging to ensure product integrity during transit
• Flexible shipping solutions based on customer requirements
• Fast response for samples and bulk orders